Glenmark Pharmaceuticals S.A. to invest in new Translational Research Group @ Biopôle
07.03.2018
Share this article
Glenmark Pharmaceuticals announces it will enhance its capabilities in translational research by opening a new discovery centre at the Biopôle campus of Lausanne.